HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat.

Abstract
In the present study we observed that lipopolysaccharide (LPS) administration provoked a characteristic reduction in body weight gain, food consumption, saccharin (but not water) consumption and nocturnal locomotor activity. It has been previously suggested that the ability of LPS to suppress the consumption of, and preference for, a palatable solution such as saccharin without altering water consumption, may represent an anhedonic response. The results of the present study demonstrate that chronic treatment with the tricyclic antidepressant (TCA) desipramine (7.5 mg/kg; i.p.) prevented LPS-induced anorexia, loss of body weight, the antidipsogenic effect and hypoactivity. In contrast, chronic treatment with the antidepressants paroxetine (7.5 mg/kg; i.p.) and venlafaxine (10 mg/kg; i.p.) failed to alter any of the LPS-induced behavioural responses. Furthermore, chronic treatment with desipramine (and to a lesser extent paroxetine) reduced the consumption of, and preference for, saccharin suggesting that these antidepressant treatments induce an "anhedonic" response in their own right. In conclusion, chronic desipramine treatment attenuated LPS-induced depressive-like behavioural symptoms in the rat. However, chronic treatment with paroxetine and venlafaxine did not significantly alter LPS-induced behavioural responses. The results of the present study support the hypothesis that TCA's may exert part of their anti-depressive efficacy through their effects on the immune system. However, this property does not appear to be shared by newer antidepressants which possess a better side effect profile than the TCA's. The suppressive effect of TCA's on proinflammatory cytokine secretion is discussed as a mechanism by which these agents alter LPS-induced behavioural responses.
AuthorsY Shen, T J Connor, Y Nolan, J P Kelly, B E Leonard
JournalLife sciences (Life Sci) Vol. 65 Issue 17 Pg. 1773-86 ( 1999) ISSN: 0024-3205 [Print] Netherlands
PMID10576557 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adrenergic Uptake Inhibitors
  • Antidepressive Agents
  • Antidepressive Agents, Tricyclic
  • Cyclohexanols
  • Endotoxins
  • Lipopolysaccharides
  • Serotonin Uptake Inhibitors
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Paroxetine
  • endotoxin, Escherichia coli
  • Venlafaxine Hydrochloride
  • Desipramine
Topics
  • Adrenergic Uptake Inhibitors (pharmacology)
  • Animals
  • Antidepressive Agents (pharmacology)
  • Antidepressive Agents, Tricyclic (pharmacology)
  • Behavior, Animal (drug effects)
  • Body Weight (drug effects)
  • Cyclohexanols (pharmacology)
  • Desipramine (pharmacology)
  • Drinking Behavior (drug effects)
  • Eating (drug effects)
  • Endotoxins (toxicity)
  • Escherichia coli
  • Interleukin-10 (blood)
  • Lipopolysaccharides (toxicity)
  • Male
  • Motor Activity (drug effects)
  • Paroxetine (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Selective Serotonin Reuptake Inhibitors (pharmacology)
  • Tumor Necrosis Factor-alpha (metabolism)
  • Venlafaxine Hydrochloride

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: